Several products seem promising, but overall data are limited Non-nicotine medications for smoking cessation

Jack E. Henningfield

Research output: Contribution to journalArticle

Abstract

The complexity of addiction to nicotine has led to consideration of drugs other than nicotine replacement medications that may be useful for one or more of the hurdles smokers face \vhen quitting. Some may lessen a withdrawal symptom, such as depressed mood, in patients who are struggling with this problem; others may substitute for the pleasure some patients derive from the slight burning sensation in the mouth while smoking. Only one non-nicotine medication has been approved by the PDA for smoking cessation - sustained-release bupropion. Large-scale studies of the other drugs are generally lacking, but some antidepressants, anxiolytics, nicotine antagonists, sensory-stimulating compounds, and other drugs may improve long-term quit rates in selected patients.

Original languageEnglish (US)
JournalJournal of Respiratory Diseases
Volume19
Issue number8 SUPPL.
StatePublished - 1998
Externally publishedYes

Fingerprint

Smoking Cessation
Nicotine
Pharmaceutical Preparations
Bupropion
Substance Withdrawal Syndrome
Pleasure
Anti-Anxiety Agents
Antidepressive Agents
Mouth
Smoking

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Several products seem promising, but overall data are limited Non-nicotine medications for smoking cessation. / Henningfield, Jack E.

In: Journal of Respiratory Diseases, Vol. 19, No. 8 SUPPL., 1998.

Research output: Contribution to journalArticle

@article{67da52fe58df4d4a9713266dda3012f1,
title = "Several products seem promising, but overall data are limited Non-nicotine medications for smoking cessation",
abstract = "The complexity of addiction to nicotine has led to consideration of drugs other than nicotine replacement medications that may be useful for one or more of the hurdles smokers face \vhen quitting. Some may lessen a withdrawal symptom, such as depressed mood, in patients who are struggling with this problem; others may substitute for the pleasure some patients derive from the slight burning sensation in the mouth while smoking. Only one non-nicotine medication has been approved by the PDA for smoking cessation - sustained-release bupropion. Large-scale studies of the other drugs are generally lacking, but some antidepressants, anxiolytics, nicotine antagonists, sensory-stimulating compounds, and other drugs may improve long-term quit rates in selected patients.",
author = "Henningfield, {Jack E.}",
year = "1998",
language = "English (US)",
volume = "19",
journal = "Journal of Respiratory Diseases",
issn = "0194-259X",
publisher = "Cliggott Publishing Co.",
number = "8 SUPPL.",

}

TY - JOUR

T1 - Several products seem promising, but overall data are limited Non-nicotine medications for smoking cessation

AU - Henningfield, Jack E.

PY - 1998

Y1 - 1998

N2 - The complexity of addiction to nicotine has led to consideration of drugs other than nicotine replacement medications that may be useful for one or more of the hurdles smokers face \vhen quitting. Some may lessen a withdrawal symptom, such as depressed mood, in patients who are struggling with this problem; others may substitute for the pleasure some patients derive from the slight burning sensation in the mouth while smoking. Only one non-nicotine medication has been approved by the PDA for smoking cessation - sustained-release bupropion. Large-scale studies of the other drugs are generally lacking, but some antidepressants, anxiolytics, nicotine antagonists, sensory-stimulating compounds, and other drugs may improve long-term quit rates in selected patients.

AB - The complexity of addiction to nicotine has led to consideration of drugs other than nicotine replacement medications that may be useful for one or more of the hurdles smokers face \vhen quitting. Some may lessen a withdrawal symptom, such as depressed mood, in patients who are struggling with this problem; others may substitute for the pleasure some patients derive from the slight burning sensation in the mouth while smoking. Only one non-nicotine medication has been approved by the PDA for smoking cessation - sustained-release bupropion. Large-scale studies of the other drugs are generally lacking, but some antidepressants, anxiolytics, nicotine antagonists, sensory-stimulating compounds, and other drugs may improve long-term quit rates in selected patients.

UR - http://www.scopus.com/inward/record.url?scp=4243824606&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=4243824606&partnerID=8YFLogxK

M3 - Article

VL - 19

JO - Journal of Respiratory Diseases

JF - Journal of Respiratory Diseases

SN - 0194-259X

IS - 8 SUPPL.

ER -